Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol® Dispersing
- 1 September 2010
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 36 (9) , 1064-1078
Abstract
Objectives: To investigate the ability of KinetiSol® Dispersing to prepare amorphous solid dispersions of itraconazole using concentration-enhancing polymers. Methods: Concentration-enhancing nature of several cellulosic polymers (HPMC, hypromellose acetate succinate) was studied using a modified in vitro dissolution test. Solid dispersions were prepared by KinetiSol® Dispersing and characterized for solid-state properties using X-ray diffraction and differential scanning calorimetry. Potency and release characteristics were also assessed by high-performance liquid chromatography. Oral bioavailability of lead formulations was also assessed in animal models. Results: Screening studies demonstrated superior concentration-enhancing performance from the hypromellose acetate succinate polymer class. Data showed that stabilization was related to molecular weight and the degree of hydrophobic substitution on the polymer such that HF > MF ≈ LF, indicating that stabilization was achieved through a combination of steric hindrance and hydrophobic interaction, supplemented by the amphiphilic nature and ionization state of the polymer. Solid dispersions exhibited amorphous solid-state behavior and provided neutral media supersaturation using a surfactant-free pH change method. Rank-order behavior was such that LF > MF > HF. Addition of Carbopol 974P increased acidic media dissolution, while providing a lower magnitude of supersaturation in neutral media because of swelling of the high viscosity gel. In vivo results for both lead compositions displayed erratic absorption was attributed to the variability of gastrointestinal pH in the animals. Conclusions: These results showed that production of amorphous solid dispersions containing concentration-enhancing polymers through KinetiSol® Dispersing can provide improved oral bioavailability; however, additional formulation techniques must be developed to minimize variability associated with natural variations in subject gastrointestinal physiology.Keywords
This publication has 45 references indexed in Scilit:
- Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole‐cyclodextrin formulationsJournal of Pharmaceutical Sciences, 2007
- Effect of Stabilizer on the Maximum Degree and Extent of Supersaturation and Oral Absorption of Tacrolimus Made By Ultra-Rapid FreezingPharmaceutical Research, 2007
- Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugsExpert Opinion on Drug Delivery, 2005
- Nanoparticle Formulation Increases Oral Bioavailability of Poorly Soluble Drugs: Approaches, Experimental Evidences and TheoryCurrent Nanoscience, 2005
- Pharmaceutical Aspects of Polymeric Nanoparticles for Oral Drug DeliveryJournal of Biomedical Nanotechnology, 2005
- Development of a supersaturable SEDDS (S‐SEDDS) formulation of paclitaxel with improved oral bioavailabilityJournal of Pharmaceutical Sciences, 2003
- Characterization of the interaction of 2‐hydroxypropyl‐β‐cyclodextrin with itraconazole at pH 2, 4, and 7Journal of Pharmaceutical Sciences, 2002
- Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl‐β‐cyclodextrin oral solution or coated‐pellet capsulesMycoses, 1999
- Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantationKidney International, 1998
- Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and StabilizationJournal of Pharmaceutical Sciences, 1996